Skip to main content
Embla Medical hf logo

Embla Medical hf — Investor Relations & Filings

Ticker · EMBLA ISIN · IS0000000040 LEI · 213800K2AVTAFWJ4DP64 CO Manufacturing
Open in API
Filings indexed 1,164 across all filing types
Latest filing 2026-02-03 Report Publication Anno…
Country IS Iceland
Listing CO EMBLA

About Embla Medical hf

https://www.emblamedical.com/

Embla Medical hf is a global provider of non-invasive orthopedic technologies and mobility solutions. The company develops, manufactures, and sells a range of products with a primary focus on prosthetics, neuro orthotics, and bracing and supports. It serves specialized healthcare providers, such as orthopedic and prosthetic clinics, hospitals, and surgery centers, through its direct sales channels. The company's stated mission is to help people live a "Life Without Limitations" by improving their mobility.

Recent filings

Filing Released Lang Actions
Embla Medical Publishes 2025 Annual Report; CEO Highlights Solid Progress and Strategic Momentum
Report Publication Announcement Classification · 1% confidence The document is a short announcement (under 5,000 characters of core text) titled 'Embla Medical Publishes 2025 Annual Report'. It explicitly states that the full report can be downloaded from a provided website link and includes a link to the PDF file. According to the 'Menu vs Meal' rule, this is an announcement of a report publication rather than the report itself, making it a Report Publication Announcement (RPA).
2026-02-03 English
Embla Medical Publishes 2025 Annual Report; CEO Highlights Solid Progress and Strategic Momentum
Annual Report (ESEF) Classification · 1% confidence FY 2025
2026-02-03 English
Embla Medical Publishes 2025 Annual Report; CEO Highlights Solid Progress and Strategic Momentum
Annual Report Classification · 1% confidence The document is clearly identified as an 'ANNUAL REPORT 2025' for Embla Medical. It contains comprehensive sections including a letter from the CEO, business highlights, financial highlights, sustainability statements, and a table of contents referencing consolidated financial statements. It is a full-year report covering company activity and performance, fitting the definition of a 10-K (Annual Report). FY 2025
2026-02-03 English
Embla Medical hf: Interim Report Q4 and Full Year 2025
Report Publication Announcement Classification · 1% confidence The document is a press release announcing the release of the Q4 and Full Year 2025 Interim Report. It provides a summary of financial highlights, CEO commentary, and guidance, but explicitly directs the reader to an external link to download the actual full report. Per the 'Menu vs Meal' rule, since this is an announcement of a report rather than the report itself, it is classified as a Report Publication Announcement (RPA). FY 2025
2026-02-03 English
Embla Medical hf: Interim Report Q4 and Full Year 2025
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim Report Q4 and Full Year 2025' and contains detailed financial statements, income statements, balance sheets, cash flow data, and management commentary on financial performance. It is a comprehensive financial report for a period shorter than a full fiscal year (Q4) and the full year, providing substantive financial data and analysis. It is not an announcement of a report, but the report itself. Q4 2025
2026-02-03 English
Embla Medical hf: Transactions in relation to Share Buyback Program
Transaction in Own Shares Classification · 1% confidence The document is an official announcement detailing specific transactions related to a share buyback program, including dates, number of shares, and purchase prices. This falls directly under the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2026-02-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.